Serous cystadenocarcinoma of the pancreas: report of a case and management reflections

World Journal of Surgical Oncology

E Felekouras²  N Brennan³  E Mantonakis²  A Manzelli⁴  A Papalambros²  A Petrou¹  K Bramis² 

[1] HPB Surgery, Nicosia Surgical Department, Cyprus;LAIKON Hospital, First Department of Surgery, University of Athens Medical School, Greece;Churchill Hospital, Oxford, UK;Hepatobiliary and Pancreatic Surgical Department, Oxford Radcliffe Hospitals NHS Foundation Trust

关键词: serous cystadenocarcinoma;    serous cystadenoma;    cystic tumors of the pancreas;    pancreatic cancer;   

Others  :  827913
DOI  :  10.1186/1477-7819-10-51

 received in 2011-03-12, accepted in 2012-03-08,  发布年份 2012

【 摘 要 】

Background

Serous adenomas represent 1-2% of pancreatic neoplasms and typically are asymptomatic not requiring any treatment and simple observation is the option of choice. Although, they carry a realistic risk of malignancy despite the general view that they never become malignant. We report a case, which, according to our best knowledge is the 27th case reported in the literature.

Methods

We reviewed the literature by performing a search in Pub Med and Medline.

Results

A 86-year old patient known to have a serous cystadenoma of the pancreas treated conservatively through a close clinical and radiological follow up which was unattended for 4 years ending up to our emergency department suffering an acute abdomen. Exploratory laparotomy revealed a perforated prepyloric ulcer which was treated accordingly. Patient died some weeks later due to severe medical co morbidities.

Conclusion

Serous cystic neoplasms of the pancreas carry a realistic risk of malignancy despite the general view that they never become malignant. In our opinion the treatment strategy of serous cystic neoplasms of the pancreas should be aggressive even in cases of remote metastases since prognosis of the disease is satisfactory

【 授权许可】

   
2012 Bramis et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Siech M, Tripp K, Schmidt-Rohlfing B, Mattfeldt T, Widmaier U, Gansauge F, Görich J, Beger HG: Cystic tumors of the pancreas: Diagnostic accuracy, pathologic observations and surgical consequences. Langenbecks Arch Surg 1998, 383:56-61.
• [2]Horvath K, Charbot JA: An aggressive resectional approach to cystic neoplasms of the pancreas. Am J Surg 1999, 178:262-274.
• [3]Tseng JF, Warshaw AL, Sahani DV, Lauwers GY, Rattner DW, Fernandezdel Castillo C: Serous cystadenoma of the pancreas: Tumor growth rates and recommendations for treatment. Ann Surg 2005, 242:413-421.
• [4]Bosman FT, Carneiro F, Hruban RH, Theise ND: WHO Classification of Tumors of the Digestive System. Volume 3. 4th edition. IARC WHO Classification of Tumors; No3
• [5]Compagno J, Oertel JE: Microcystic adenomas of the pancreas(glycogen-rich cystadenomas). Am J Clin Pathol 1978, 69:289-298.
• [6]Compagno J, Oertel JE: Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma): A clinicopathological study of 41 cases. Am J Clin Parhol 1978, 69:573-580.
• [7]Kloppel G, Solcia E, Longnecker DS, Capella C, Sobin LH: Histological typing of tumors of the exocrine pancreas. In WHO international histological classification of tumors. 2nd edition. Berlin: Springer; 1996.
• [8]George DH, Murphy F, Michalski R, Ulmer BG: Serous cystadenocarcinoma of the pancreas: A new entity? 1989, 13:61-66.
• [9]Jonathan KingC, Tina NgT, Stephen WhiteC, Cortina Galen, Howard ReberA, Joe Hines O: Pancreatic Serous Cystadenocarcinoma: A case report an review of the literature. J Gastrointest Surg 2009, 13:1864-1868.
• [10]Galanis C, Zamani A, Cameron JL, Campell KA, Lillemoe KD, Caparelli D, Chang D, Hruban RH, Yeo CJ: Resected serous cystic neoplasms of the pancreas: A review of 158 patients with recommendations for treatment. J Gastrointest Surg 2007, 11:820-826.
• [11]Schmidt-Rohlfing B, Siech M, Mattfeldt T, Schoenberg MH, Bager HG: Cystic neoplasms of the pancreas: surgical treatment and outcome. Z Gastroenterol 1998, 36:939-945.
• [12]Wu CM, Fisherman EK, Hruban RK: Serous cystic neoplasm involving the pancreas and liver: A unusual clinical entity. Abdom Imaging 1999, 24:75-77.
• [13]Kimura W, Makuuchi M: Operative indications for cystic lesions of the pancreas with malignant potential: Our experience. Hepatogastroenterology 1999, 46:483-491.
• [14]Abe H, Kubota K, Mori M, Miki K, Minagawa M, Noise T, Kimura W, Makuutchi M: Serous cystadenoma of the pancreas with invasive growth: Benign or malignant? Am J Gastroenterol 1989, 93:1963-1966.
• [15]Strobel O, Z'graggen K, Schmitz-Winnenthal FH, Friess H, Kappeler A, Zimmermann A, Uhl W, Buchler MW: Risk of malignancy in serous cystic neoplasms of the pancreas. Digestion 2003, 68:24-33.
• [16]Friebe V, Keck T, Mattem D, Schmidt-Graeff A, Wemer M, Mikami Y, Adam U, Hopt UT: Serous cystadenocarcinoma of the pancreas: Management of a rare entity. Pancreas 2005, 31:182-187.
• [17]Verbesey JE, Munson JL: Pancreatic cystic neoplasms. Surg Clin N Am 90 2010, 411-425.
• [18]Federle M, Mc Grath K: Cystic neoplasms of the pancreas. Gastroenterol Clin N Am 36 2007, 365-376.
• [19]Allen PJ, Jaques DP, D'Angelica M, Bowne WB, Conlon KC, Brennan MF: Cystic lesions of the pancreas: selection criteria for operative and non operative management in 209 patients. J Gastrointest Surg 7 2003, 970-977.
• [20]Garcea G, Ong SL, Rajesh A, Neal CP, Pollard CA, Berry DP, Dennison AR: Cystic lesions of the pancreas. A diagnostic and management dilemma. Pancreatology 2008, 8(3):236-51.
• [21]Ferrone CR, Correa-Gallego C, Warshaw AL, Brugge WR, Forcione DG, Thayer SP, Fernandez-del Castillo C: Current trends in pancreatic cystic neoplasms. Arch Surg 2009, 144(5):448-54.
• [22]McKay A, Sutherland FR, Bathe OF, Dixon E: Morbidity and mortality following multivisceral resections in complex hepatic and pancreatic surgery. J Gastrointest Surg 2008, 12(1):86-90.